TrademarkDir
ALPX
LIVE

Serial Number

79285941

Owner

European Molecular Biology Laboratory

Attorney

Nicholas D. Wells

Filing Date

Apr 1, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ALPX Trademark

Serial Number: 79285941 • Registration: 6391798

ALPX is a trademark filed by European Molecular Biology Laboratory on April 1, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

European Molecular Biology Laboratory (26 trademarks)

Postfach 102209
Heidelberg 69012 , DE

Entity Type: 06

Trademark Details

Filing Date

April 1, 2020

Registration Date

June 22, 2021

Published for Opposition

April 6, 2021

Goods & Services

Scientific apparatus and instruments, namely ultra-high vacuum chambers, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, biologics, contaminants; optical receivers, optical mirrors and optical inspection apparatus; spectrophotometer for measuring relative DNA, RNA and protein; data processing equipment; downloadable and recorded computer software for data processing and use in the field of structural biology

[ Pharmaceutical preparations for the treatment of infectious diseases, viral infections, psychiatric diseases and disorders and cancer; ] Veterinary preparations for the treatment of infectious diseases, viral infections, psychiatric diseases and disorders and cancer; diagnostic preparations for medical and veterinary purposes; vaccines; scaffold-proteins for medical diagnosis purposes; medical diagnostic cell-based assays for testing of bodily fluids; antibodies and immunoglobulins to prevent infectious diseases and for the treatment of cancer, small molecule compounds for medical use and drug delivery * ; * all aforementioned goods excluding bulk organic and bulk inorganic products and not in oral dosage form

medical services; medical diagnostic services; medical services in the field of personalized medicine; medical modification of molecules to enhance its usefulness as a drug

Scientific and technological services, namely, research and design in the field of drug discovery and development and commercialization of solutions for structural biology; Scientific research in the field of drug discovery and development and commercialization of solutions for structural biology * ; * Scientific and technological services, namely, scientific research, in the field of drug discovery and development * ; * industrial analysis and research services, namely, pharmaceutical and biomedical research services; drug discovery services; scientific services, namely, laboratory, services for structure analysis, modification of antibodies, peptides and proteins * ; * all aforementioned services excluding drug delivery and drug formulation

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 30, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 30, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 30, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 30, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 30, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 30, 2025 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 29, 2024 NREP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Aug 24, 2022 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 17, 2022 INPR
CORRECTION UNDER SECTION 7 - PROCESSED
May 11, 2022 COC.
ELECTRONIC RECORD REVIEW COMPLETE
May 11, 2022 FIXD
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 28, 2022 APRE
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 13, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jan 3, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 3, 2022 XXCR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 24, 2021 ERRR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Dec 22, 2021 LIMN
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Dec 21, 2021 CORR
CORRECTION UNDER SECTION 7 - PROCESSED
Dec 19, 2021 COC.
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Dec 15, 2021 CORN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Dec 15, 2021 LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Dec 15, 2021 LIMN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Dec 15, 2021 CORN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Dec 15, 2021 LIMN
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 13, 2021 APRE
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Dec 8, 2021 CORN
OTQR WITHDRAWAL FROM PUBLICATION
Nov 29, 2021 WDRL
USPTO CORRECTION PROCESSED BY IB
Nov 29, 2021 RINX
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 23, 2021 CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 23, 2021 CRCV
LIMITATION OF GOODS RECEIVED FROM IB
Nov 21, 2021 LIMG
LIMITATION OF GOODS RECEIVED FROM IB
Nov 21, 2021 LIMG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 17, 2021 APRE
CORRECTION UNDER SECTION 7 - PROCESSED
Nov 17, 2021 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 17, 2021 APRE
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Nov 17, 2021 LIMN
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 8, 2021 CRCV
LIMITATION OF GOODS RECEIVED FROM IB
Nov 6, 2021 LIMG
LIMITATION OF GOODS RECEIVED FROM IB
Nov 6, 2021 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 4, 2021 FINO
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Nov 3, 2021 LIMN
CORRECTION TRANSACTION RECEIVED FROM IB
Oct 24, 2021 CRCV
LIMITATION OF GOODS RECEIVED FROM IB
Oct 23, 2021 LIMG
OTQR WITHDRAWAL FROM PUBLICATION
Oct 20, 2021 WDRL
FINAL DISPOSITION NOTICE SENT TO IB
Oct 13, 2021 FICS
FINAL DISPOSITION PROCESSED
Oct 13, 2021 FIMP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Oct 12, 2021 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Oct 12, 2021 COC.
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 22, 2021 FICR
ASSIGNED TO PARALEGAL
Sep 3, 2021 PLGL
CORRECTION UNDER SECTION 7 - PROCESSED
Sep 2, 2021 COC.
NEW REPRESENTATIVE AT IB RECEIVED
Aug 28, 2021 NREP
TEAS SECTION 7 REQUEST RECEIVED
Jul 4, 2021 ES7R
LIMITATION OF GOODS RECEIVED FROM IB
Jun 27, 2021 LIMG
POST PUBLICATION AMENDMENT – NOT ENTERED
Jun 25, 2021 CHPN
ASSIGNED TO PETITION STAFF
Jun 23, 2021 APET
REGISTERED-PRINCIPAL REGISTER
Jun 22, 2021 R.PR
TEAS POST PUBLICATION AMENDMENT RECEIVED
May 4, 2021 EPPA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 30, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 30, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 30, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 30, 2021 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 6, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Apr 5, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2021 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 12, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 12, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 2, 2020 RFCR
NON-FINAL ACTION WRITTEN
Aug 1, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 21, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
May 26, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 22, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 21, 2020 REPR

Related Trademarks

More from this Owner

EPITOME THERAPEUTICS logo

EPITOME THERAPEUTICS

CERELIXIS

CERELIXIS

CERELIXIS

CERELIXIS

CERELIXIS

CERELIXIS

POCKETANALYSER

POCKETANALYSER

POCKETANALYSER

POCKETANALYSER